Sort by
Items per page

Send to

Choose Destination

Best matches for resveratrol lung cancer:

Search results

Items: 1 to 20 of 243


The Role of NF-κB and AHR Transcription Factors in Lead-Induced Lung Toxicity in Human Lung Cancer A549 Cells.

Attafi IM, Albakheet SA, Korashy HM.

Toxicol Mech Methods. 2019 Nov 4:1-32. doi: 10.1080/15376516.2019.1687629. [Epub ahead of print]


PRMT5 Promotes Human Lung Cancer Cell Apoptosis via Akt/Gsk3β Signaling Induced by Resveratrol.

Li Y, Yang Y, Liu X, Long Y, Zheng Y.

Cell Transplant. 2019 Oct 30:963689719885083. doi: 10.1177/0963689719885083. [Epub ahead of print]


Resveratrol suppresses neutrophil activation via inhibition of Src family kinases to attenuate lung injury.

Tsai YF, Chen CY, Chang WY, Syu YT, Hwang TL.

Free Radic Biol Med. 2019 Dec;145:67-77. doi: 10.1016/j.freeradbiomed.2019.09.021. Epub 2019 Sep 21.


Resveratrol solid lipid nanoparticles to trigger credible inhibition of doxorubicin cardiotoxicity.

Zhang L, Zhu K, Zeng H, Zhang J, Pu Y, Wang Z, Zhang T, Wang B.

Int J Nanomedicine. 2019 Jul 31;14:6061-6071. doi: 10.2147/IJN.S211130. eCollection 2019.


Resveratrol inhibits the invasion and metastasis of colon cancer through reversal of epithelial‑ mesenchymal transition via the AKT/GSK‑3β/Snail signaling pathway.

Yuan L, Zhou M, Huang D, Wasan HS, Zhang K, Sun L, Huang H, Ma S, Shen M, Ruan S.

Mol Med Rep. 2019 Sep;20(3):2783-2795. doi: 10.3892/mmr.2019.10528. Epub 2019 Jul 25.


miR-448 promotes progression of non-small-cell lung cancer via targeting SIRT1.

Qi H, Wang H, Pang D.

Exp Ther Med. 2019 Sep;18(3):1907-1913. doi: 10.3892/etm.2019.7738. Epub 2019 Jul 5.


Resveratrol induced premature senescence and inhibited epithelial-mesenchymal transition of cancer cells via induction of tumor suppressor Rad9.

Chen KY, Chen CC, Chang YC, Chang MC.

PLoS One. 2019 Jul 16;14(7):e0219317. doi: 10.1371/journal.pone.0219317. eCollection 2019.


Phytochemicals as Modulators of Long Non-Coding RNAs and Inhibitors of Cancer-Related Carbonic Anhydrases.

Saghafi T, Taheri RA, Parkkila S, Emameh RZ.

Int J Mol Sci. 2019 Jun 15;20(12). pii: E2939. doi: 10.3390/ijms20122939. Review.


Resveratrol Inhibits the Migration and Metastasis of MDA-MB-231 Human Breast Cancer by Reversing TGF-β1-Induced Epithelial-Mesenchymal Transition.

Sun Y, Zhou QM, Lu YY, Zhang H, Chen QL, Zhao M, Su SB.

Molecules. 2019 Mar 21;24(6). pii: E1131. doi: 10.3390/molecules24061131.


Resveratrol suppresses the invasion and migration of human gastric cancer cells via inhibition of MALAT1-mediated epithelial-to-mesenchymal transition.

Yang Z, Xie Q, Chen Z, Ni H, Xia L, Zhao Q, Chen Z, Chen P.

Exp Ther Med. 2019 Mar;17(3):1569-1578. doi: 10.3892/etm.2018.7142. Epub 2018 Dec 28.


Health risk of metal exposure via inhalation of cigarette sidestream smoke particulate matter.

Cheng LC, Lin CJ, Liu HJ, Li LA.

Environ Sci Pollut Res Int. 2019 Apr;26(11):10835-10845. doi: 10.1007/s11356-019-04257-4. Epub 2019 Feb 18.


Trans-3,5,4´-trimethoxystilbene reduced gefitinib resistance in NSCLCs via suppressing MAPK/Akt/Bcl-2 pathway by upregulation of miR-345 and miR-498.

Lu M, Liu B, Xiong H, Wu F, Hu C, Liu P.

J Cell Mol Med. 2019 Apr;23(4):2431-2441. doi: 10.1111/jcmm.14086. Epub 2019 Jan 30.


Liquid crystalline assembly for potential combinatorial chemo-herbal drug delivery to lung cancer cells.

Abdelaziz HM, Elzoghby AO, Helmy MW, Samaha MW, Fang JY, Freag MS.

Int J Nanomedicine. 2019 Jan 11;14:499-517. doi: 10.2147/IJN.S188335. eCollection 2019.


[Emerging Actions of Pterostilebene on Cancer Research].

Zhang X, Zhang J, Xu L, Ma Z, Di S, Gao Y, Li X, Yan X, Zhang H.

Zhongguo Fei Ai Za Zhi. 2018 Dec 20;21(12):931-936. doi: 10.3779/j.issn.1009-3419.2018.12.01. Review. Chinese.


Resveratrol-Responsive CArG Elements from the Egr-1 Promoter for the Induction of GADD45α to Arrest the G2/M Transition.

Shi Q, Bhatia D.

Methods Mol Biol. 2019;1895:111-122. doi: 10.1007/978-1-4939-8922-5_9.


Resveratrol epigenetically regulates the expression of zinc finger protein 36 in non‑small cell lung cancer cell lines.

Fudhaili A, Yoon NA, Kang S, Ryu J, Jeong JY, Lee DH, Kang SS.

Oncol Rep. 2019 Feb;41(2):1377-1386. doi: 10.3892/or.2018.6898. Epub 2018 Nov 30.


Potential of curcumin and resveratrol as biochemical and biophysical modulators during lung cancer in rats.

Liu D, He B, Lin L, Malhotra A, Yuan N.

Drug Chem Toxicol. 2019 May;42(3):328-334. doi: 10.1080/01480545.2018.1523921. Epub 2018 Nov 28.


Resveratrol, an activator of SIRT1, induces protective autophagy in non-small-cell lung cancer via inhibiting Akt/mTOR and activating p38-MAPK.

Wang J, Li J, Cao N, Li Z, Han J, Li L.

Onco Targets Ther. 2018 Nov 2;11:7777-7786. doi: 10.2147/OTT.S159095. eCollection 2018.


Evaluation of resveratrol radiomodifying potential for radiotherapy treatment.

Banegas YC, Ocolotobiche EE, Padula G, Córdoba EE, Fernández E, Güerci AM.

Mutat Res Genet Toxicol Environ Mutagen. 2018 Dec;836(Pt B):79-83. doi: 10.1016/j.mrgentox.2018.06.004. Epub 2018 Jun 8.


The red wine component ellagic acid induces autophagy and exhibits anti-lung cancer activity in vitro and in vivo.

Duan J, Zhan JC, Wang GZ, Zhao XC, Huang WD, Zhou GB.

J Cell Mol Med. 2019 Jan;23(1):143-154. doi: 10.1111/jcmm.13899. Epub 2018 Oct 24.

Supplemental Content

Loading ...
Support Center